Global Recombinant Human Erythropoietin (rhEPO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 93

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Recombinant Human Erythropoietin (rhEPO) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

The Global Info Research report includes an overview of the development of the Recombinant Human Erythropoietin (rhEPO) industry chain, the market status of Hospitals (ESRD, Cancer), Retail Pharmacies (ESRD, Cancer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant Human Erythropoietin (rhEPO).

Regionally, the report analyzes the Recombinant Human Erythropoietin (rhEPO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant Human Erythropoietin (rhEPO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Recombinant Human Erythropoietin (rhEPO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant Human Erythropoietin (rhEPO) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., ESRD, Cancer).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant Human Erythropoietin (rhEPO) market.

Regional Analysis: The report involves examining the Recombinant Human Erythropoietin (rhEPO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant Human Erythropoietin (rhEPO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Recombinant Human Erythropoietin (rhEPO):
Company Analysis: Report covers individual Recombinant Human Erythropoietin (rhEPO) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant Human Erythropoietin (rhEPO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Retail Pharmacies).

Technology Analysis: Report covers specific technologies relevant to Recombinant Human Erythropoietin (rhEPO). It assesses the current state, advancements, and potential future developments in Recombinant Human Erythropoietin (rhEPO) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant Human Erythropoietin (rhEPO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Recombinant Human Erythropoietin (rhEPO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
ESRD
Cancer
HIV
Wounds and Neural Disease

Market segment by Application
Hospitals
Retail Pharmacies

Major players covered
3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Erythropoietin (rhEPO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Erythropoietin (rhEPO), with price, sales, revenue and global market share of Recombinant Human Erythropoietin (rhEPO) from 2019 to 2024.
Chapter 3, the Recombinant Human Erythropoietin (rhEPO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Erythropoietin (rhEPO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Recombinant Human Erythropoietin (rhEPO) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Erythropoietin (rhEPO).
Chapter 14 and 15, to describe Recombinant Human Erythropoietin (rhEPO) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Recombinant Human Erythropoietin (rhEPO)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 ESRD
        1.3.3 Cancer
        1.3.4 HIV
        1.3.5 Wounds and Neural Disease
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Retail Pharmacies
    1.5 Global Recombinant Human Erythropoietin (rhEPO) Market Size & Forecast
        1.5.1 Global Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity (2019-2030)
        1.5.3 Global Recombinant Human Erythropoietin (rhEPO) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 3SBio
        2.1.1 3SBio Details
        2.1.2 3SBio Major Business
        2.1.3 3SBio Recombinant Human Erythropoietin (rhEPO) Product and Services
        2.1.4 3SBio Recombinant Human Erythropoietin (rhEPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 3SBio Recent Developments/Updates
    2.2 Shanghai Chemo
        2.2.1 Shanghai Chemo Details
        2.2.2 Shanghai Chemo Major Business
        2.2.3 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Product and Services
        2.2.4 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Shanghai Chemo Recent Developments/Updates
    2.3 Chengdu Diao
        2.3.1 Chengdu Diao Details
        2.3.2 Chengdu Diao Major Business
        2.3.3 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Product and Services
        2.3.4 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Chengdu Diao Recent Developments/Updates
    2.4 NCPC Genetech
        2.4.1 NCPC Genetech Details
        2.4.2 NCPC Genetech Major Business
        2.4.3 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Product and Services
        2.4.4 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 NCPC Genetech Recent Developments/Updates
    2.5 Kyowa Hakko Kirin
        2.5.1 Kyowa Hakko Kirin Details
        2.5.2 Kyowa Hakko Kirin Major Business
        2.5.3 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Product and Services
        2.5.4 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Kyowa Hakko Kirin Recent Developments/Updates
    2.6 Shandong Kexing
        2.6.1 Shandong Kexing Details
        2.6.2 Shandong Kexing Major Business
        2.6.3 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Product and Services
        2.6.4 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Shandong Kexing Recent Developments/Updates
    2.7 Ahua Pharmaceutical
        2.7.1 Ahua Pharmaceutical Details
        2.7.2 Ahua Pharmaceutical Major Business
        2.7.3 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Product and Services
        2.7.4 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Ahua Pharmaceutical Recent Developments/Updates
    2.8 Biosidus
        2.8.1 Biosidus Details
        2.8.2 Biosidus Major Business
        2.8.3 Biosidus Recombinant Human Erythropoietin (rhEPO) Product and Services
        2.8.4 Biosidus Recombinant Human Erythropoietin (rhEPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Biosidus Recent Developments/Updates
    2.9 Dragon Pharma
        2.9.1 Dragon Pharma Details
        2.9.2 Dragon Pharma Major Business
        2.9.3 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Product and Services
        2.9.4 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Dragon Pharma Recent Developments/Updates

3 Competitive Environment: Recombinant Human Erythropoietin (rhEPO) by Manufacturer
    3.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Manufacturer (2019-2024)
    3.3 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Recombinant Human Erythropoietin (rhEPO) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Recombinant Human Erythropoietin (rhEPO) Manufacturer Market Share in 2023
        3.4.2 Top 6 Recombinant Human Erythropoietin (rhEPO) Manufacturer Market Share in 2023
    3.5 Recombinant Human Erythropoietin (rhEPO) Market: Overall Company Footprint Analysis
        3.5.1 Recombinant Human Erythropoietin (rhEPO) Market: Region Footprint
        3.5.2 Recombinant Human Erythropoietin (rhEPO) Market: Company Product Type Footprint
        3.5.3 Recombinant Human Erythropoietin (rhEPO) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size by Region
        4.1.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Region (2019-2030)
        4.1.2 Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Region (2019-2030)
        4.1.3 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Region (2019-2030)
    4.2 North America Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030)
    4.3 Europe Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030)
    4.4 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030)
    4.5 South America Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030)
    4.6 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2030)
    5.2 Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Type (2019-2030)
    5.3 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2030)
    6.2 Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Application (2019-2030)
    6.3 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Application (2019-2030)

7 North America
    7.1 North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2030)
    7.2 North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2030)
    7.3 North America Recombinant Human Erythropoietin (rhEPO) Market Size by Country
        7.3.1 North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2019-2030)
        7.3.2 North America Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2030)
    8.2 Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2030)
    8.3 Europe Recombinant Human Erythropoietin (rhEPO) Market Size by Country
        8.3.1 Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2019-2030)
        8.3.2 Europe Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market Size by Region
        9.3.1 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2030)
    10.2 South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2030)
    10.3 South America Recombinant Human Erythropoietin (rhEPO) Market Size by Country
        10.3.1 South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2019-2030)
        10.3.2 South America Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Market Size by Country
        11.3.1 Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Recombinant Human Erythropoietin (rhEPO) Market Drivers
    12.2 Recombinant Human Erythropoietin (rhEPO) Market Restraints
    12.3 Recombinant Human Erythropoietin (rhEPO) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Recombinant Human Erythropoietin (rhEPO) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Recombinant Human Erythropoietin (rhEPO)
    13.3 Recombinant Human Erythropoietin (rhEPO) Production Process
    13.4 Recombinant Human Erythropoietin (rhEPO) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Recombinant Human Erythropoietin (rhEPO) Typical Distributors
    14.3 Recombinant Human Erythropoietin (rhEPO) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. 3SBio Basic Information, Manufacturing Base and Competitors
    Table 4. 3SBio Major Business
    Table 5. 3SBio Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 6. 3SBio Recombinant Human Erythropoietin (rhEPO) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. 3SBio Recent Developments/Updates
    Table 8. Shanghai Chemo Basic Information, Manufacturing Base and Competitors
    Table 9. Shanghai Chemo Major Business
    Table 10. Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 11. Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Shanghai Chemo Recent Developments/Updates
    Table 13. Chengdu Diao Basic Information, Manufacturing Base and Competitors
    Table 14. Chengdu Diao Major Business
    Table 15. Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 16. Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Chengdu Diao Recent Developments/Updates
    Table 18. NCPC Genetech Basic Information, Manufacturing Base and Competitors
    Table 19. NCPC Genetech Major Business
    Table 20. NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 21. NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. NCPC Genetech Recent Developments/Updates
    Table 23. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
    Table 24. Kyowa Hakko Kirin Major Business
    Table 25. Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 26. Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Kyowa Hakko Kirin Recent Developments/Updates
    Table 28. Shandong Kexing Basic Information, Manufacturing Base and Competitors
    Table 29. Shandong Kexing Major Business
    Table 30. Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 31. Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Shandong Kexing Recent Developments/Updates
    Table 33. Ahua Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 34. Ahua Pharmaceutical Major Business
    Table 35. Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 36. Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Ahua Pharmaceutical Recent Developments/Updates
    Table 38. Biosidus Basic Information, Manufacturing Base and Competitors
    Table 39. Biosidus Major Business
    Table 40. Biosidus Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 41. Biosidus Recombinant Human Erythropoietin (rhEPO) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Biosidus Recent Developments/Updates
    Table 43. Dragon Pharma Basic Information, Manufacturing Base and Competitors
    Table 44. Dragon Pharma Major Business
    Table 45. Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 46. Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Dragon Pharma Recent Developments/Updates
    Table 48. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 49. Global Recombinant Human Erythropoietin (rhEPO) Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 50. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 51. Market Position of Manufacturers in Recombinant Human Erythropoietin (rhEPO), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 52. Head Office and Recombinant Human Erythropoietin (rhEPO) Production Site of Key Manufacturer
    Table 53. Recombinant Human Erythropoietin (rhEPO) Market: Company Product Type Footprint
    Table 54. Recombinant Human Erythropoietin (rhEPO) Market: Company Product Application Footprint
    Table 55. Recombinant Human Erythropoietin (rhEPO) New Market Entrants and Barriers to Market Entry
    Table 56. Recombinant Human Erythropoietin (rhEPO) Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Region (2019-2024) & (K Units)
    Table 58. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Region (2025-2030) & (K Units)
    Table 59. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Region (2019-2024) & (USD Million)
    Table 60. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Region (2025-2030) & (USD Million)
    Table 61. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Region (2019-2024) & (USD/Unit)
    Table 62. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Region (2025-2030) & (USD/Unit)
    Table 63. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2024) & (K Units)
    Table 64. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2025-2030) & (K Units)
    Table 65. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Type (2019-2024) & (USD Million)
    Table 66. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Type (2025-2030) & (USD Million)
    Table 67. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Type (2019-2024) & (USD/Unit)
    Table 68. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Type (2025-2030) & (USD/Unit)
    Table 69. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2024) & (K Units)
    Table 70. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2025-2030) & (K Units)
    Table 71. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Application (2019-2024) & (USD/Unit)
    Table 74. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Application (2025-2030) & (USD/Unit)
    Table 75. North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2024) & (K Units)
    Table 76. North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2025-2030) & (K Units)
    Table 77. North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2024) & (K Units)
    Table 78. North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2025-2030) & (K Units)
    Table 79. North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2019-2024) & (K Units)
    Table 80. North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2025-2030) & (K Units)
    Table 81. North America Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2019-2024) & (USD Million)
    Table 82. North America Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2025-2030) & (USD Million)
    Table 83. Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2024) & (K Units)
    Table 84. Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2025-2030) & (K Units)
    Table 85. Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2024) & (K Units)
    Table 86. Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2025-2030) & (K Units)
    Table 87. Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2019-2024) & (K Units)
    Table 88. Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2025-2030) & (K Units)
    Table 89. Europe Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2019-2024) & (USD Million)
    Table 90. Europe Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2025-2030) & (USD Million)
    Table 91. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2024) & (K Units)
    Table 92. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2025-2030) & (K Units)
    Table 93. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2024) & (K Units)
    Table 94. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2025-2030) & (K Units)
    Table 95. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Region (2019-2024) & (K Units)
    Table 96. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Region (2025-2030) & (K Units)
    Table 97. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Consumption Value by Region (2019-2024) & (USD Million)
    Table 98. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Consumption Value by Region (2025-2030) & (USD Million)
    Table 99. South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2024) & (K Units)
    Table 100. South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2025-2030) & (K Units)
    Table 101. South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2024) & (K Units)
    Table 102. South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2025-2030) & (K Units)
    Table 103. South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2019-2024) & (K Units)
    Table 104. South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Country (2025-2030) & (K Units)
    Table 105. South America Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2019-2024) & (USD Million)
    Table 106. South America Recombinant Human Erythropoietin (rhEPO) Consumption Value by Country (2025-2030) & (USD Million)
    Table 107. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2019-2024) & (K Units)
    Table 108. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Type (2025-2030) & (K Units)
    Table 109. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2019-2024) & (K Units)
    Table 110. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Application (2025-2030) & (K Units)
    Table 111. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Region (2019-2024) & (K Units)
    Table 112. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity by Region (2025-2030) & (K Units)
    Table 113. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Consumption Value by Region (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Consumption Value by Region (2025-2030) & (USD Million)
    Table 115. Recombinant Human Erythropoietin (rhEPO) Raw Material
    Table 116. Key Manufacturers of Recombinant Human Erythropoietin (rhEPO) Raw Materials
    Table 117. Recombinant Human Erythropoietin (rhEPO) Typical Distributors
    Table 118. Recombinant Human Erythropoietin (rhEPO) Typical Customers
List of Figures
    Figure 1. Recombinant Human Erythropoietin (rhEPO) Picture
    Figure 2. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Type in 2023
    Figure 4. ESRD Examples
    Figure 5. Cancer Examples
    Figure 6. HIV Examples
    Figure 7. Wounds and Neural Disease Examples
    Figure 8. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 9. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Application in 2023
    Figure 10. Hospitals Examples
    Figure 11. Retail Pharmacies Examples
    Figure 12. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity (2019-2030) & (K Units)
    Figure 15. Global Recombinant Human Erythropoietin (rhEPO) Average Price (2019-2030) & (USD/Unit)
    Figure 16. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Manufacturer in 2023
    Figure 17. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Manufacturer in 2023
    Figure 18. Producer Shipments of Recombinant Human Erythropoietin (rhEPO) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 19. Top 3 Recombinant Human Erythropoietin (rhEPO) Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Top 6 Recombinant Human Erythropoietin (rhEPO) Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Region (2019-2030)
    Figure 22. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Region (2019-2030)
    Figure 23. North America Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030) & (USD Million)
    Figure 24. Europe Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030) & (USD Million)
    Figure 25. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030) & (USD Million)
    Figure 26. South America Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030) & (USD Million)
    Figure 27. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Consumption Value (2019-2030) & (USD Million)
    Figure 28. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 29. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Type (2019-2030)
    Figure 30. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Type (2019-2030) & (USD/Unit)
    Figure 31. Global Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 32. Global Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Application (2019-2030)
    Figure 33. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Application (2019-2030) & (USD/Unit)
    Figure 34. North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 35. North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 36. North America Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Country (2019-2030)
    Figure 37. North America Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Country (2019-2030)
    Figure 38. United States Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Canada Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Mexico Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 42. Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 43. Europe Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Country (2019-2030)
    Figure 44. Europe Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Country (2019-2030)
    Figure 45. Germany Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. France Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. United Kingdom Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Russia Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Italy Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 51. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 52. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Region (2019-2030)
    Figure 53. Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Region (2019-2030)
    Figure 54. China Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Japan Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Korea Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. India Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Southeast Asia Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Australia Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 61. South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 62. South America Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Country (2019-2030)
    Figure 63. South America Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Country (2019-2030)
    Figure 64. Brazil Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Argentina Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 67. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 68. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Quantity Market Share by Region (2019-2030)
    Figure 69. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Consumption Value Market Share by Region (2019-2030)
    Figure 70. Turkey Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Egypt Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Saudi Arabia Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. South Africa Recombinant Human Erythropoietin (rhEPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Recombinant Human Erythropoietin (rhEPO) Market Drivers
    Figure 75. Recombinant Human Erythropoietin (rhEPO) Market Restraints
    Figure 76. Recombinant Human Erythropoietin (rhEPO) Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Recombinant Human Erythropoietin (rhEPO) in 2023
    Figure 79. Manufacturing Process Analysis of Recombinant Human Erythropoietin (rhEPO)
    Figure 80. Recombinant Human Erythropoietin (rhEPO) Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma

Related Reports

Global Recombinant Human Erythropoietin (rhEPO) Supply, Demand and Key Producers, 2023-2029

Global Recombinant Human Erythropoietin (rhEPO) Supply, Demand and Key Producers, 2023-2029

date 05 Aug 2023

date Pharma & Healthcare

The global Recombinant Human Erythropoietin (rhEPO) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Recombinant Human Erythropoietin (rhEPO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Recombinant Human Erythropoietin (rhEPO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 05 Aug 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Human Erythropoietin (rhEPO) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Product Tags

Recombinant Human Erythropoietin (rhEPO)

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>